The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Priorities for the National Vaccine Plan
IOM (Institute of Medicine). 2000. Vaccines for the 21st Century. Washington, DC: National Academy Press.
Klein, J.O., and M.G. Myers. 2006. Strengthening the supply of routinely administered vaccines in the United States: Problems and proposed solutions. Clin Infect Dis 42(Suppl 3):S97-S103.
Neumann, P.J., A.B. Rosen, D. Greenberg, N.V. Olchanski, R. Pande, R.H. Chapman, P.W. Stone, S. Ondategui-Parra, J. Nadai, J.E. Siegel, and M.C. Weinstein. 2005. Can we better prioritize resources for cost-utility research? Med Decis Making 25(4):429-436.
Poland, G.A., R.M. Jacobson, and I.G. Ovsyannikova. 2009. Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 27(25-26):3240-3244.
Strikas, R. 2008 (March 3). The National Vaccine Plan Process—Update. Presentation to the IOM Committee on Review of Priorities for the National Vaccine Plan. Washington, DC: IOM.
Vellozzi, C. 2009. Monitoring the Safety of Influenza A (H1N1) 2009 Monovalent Vaccines(PowerPoint Presentation). Immunization Safety Office, Division of Healthcare Quality Promotion. Atlanta, GA: CDC.